Physician profile
Robert Meislin
NPI 1225024631
$720,209.32
in general payments reported to CMS, 2019-2025
14 companies · $116K in 2025
The $116K reported for 2025 was more than what 97% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $7,888 · 2021: $28K · 2022: $316K · 2023: $42K · 2024: $187K · 2025: $116K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $277K · Consulting Fee: $56K · Food and Beverage: $5,855 · Travel and Lodging: $4,651 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $276,869.64 |
| Consulting Fee | $55,546.29 |
| Food and Beverage | $5,855.43 |
| Travel and Lodging | $4,651.45 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $605,793.59 | 2022-2025 | Biobrace 23mm |
| Medical Device Business Services, INC. | $56,161.31 | 2019-2024 | Healix Knotless Peek, N/A, Orthocord |
| Depuy Synthes Products, INC. | $27,293.82 | 2021-2024 | Healix Knotless Peek, N/A, Intrafix |
| Biorez, INC. | $17,600.00 | 2022 | |
| Arcuro Medical INC | $6,200.00 | 2022-2025 | Superball |
| Smith+Nephew, INC. | $3,103.94 | 2019-2021 | |
| Gotham Surgical Solutions & Devices, INC. | $1,467.98 | 2019 | |
| Arthrex, INC. | $1,160.00 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $408.00 | 2019 | |
| Stryker Corporation | $350.13 | 2023 | Simpliciti |
| Miach Orthopaedics, INC. | $300.07 | 2024 | |
| Depuy Synthes Sales INC. | $235.08 | 2022-2024 | Rigidloop, Dynacord |
| Joint Restoration Foundation, INC. | $80.40 | 2019 | |
| Brainlab, INC. | $55.00 | 2024 | Surgical Planning and Navigation Radiation Treatment Planning and Positioning |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$50,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Meislin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.